UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Seminars in immunopathology, ISSN 1863-2297, 9/2011, Volume 33, Issue 5, pp. 419 - 440
Antigen presentation | Biomedicine | Immunology | Immunomodulation | Internal Medicine | Exosomes | Intercellular communication | Pathology | Life Sciences & Biomedicine | Science & Technology | Exosomes - metabolism | Neoplasms - metabolism | Antigen-Presenting Cells - metabolism | Communicable Diseases - therapy | Humans | Cell Communication | Antigen Presentation - immunology | Neoplasms - therapy | Animals | Biological Transport | Neoplasms - immunology | Immunotherapy | Communicable Diseases - immunology | Exosomes - immunology | Exosomes - chemistry | Antigens | RNA | Membrane proteins | Protein binding | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 04/2017, Volume 23, Issue 8, pp. 1920 - 1928
Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Neoplasms - mortality | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Disease Progression | Neoplasms - drug therapy | Young Adult | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Aged | Neoplasms - pathology | Clinical Trials, Phase I as Topic | Drugs | Medical research | Therapy | Growth rate | PD-1 protein | Clinical trials | Medical records | Survival | Patients | Immunosuppressive agents | Immune checkpoint | Experimental design | Older people | PD-L1 protein | Lesions | Cancer | Geriatrics | Index Medicus
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 01/2019, Volume 106, pp. 144 - 159
NSCLC | Immunotherapy | Predictive biomarkers | Lung cancer | PD-L1 | Tumour mutational burden | Microsatellite instability | Tumour microenvironment | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Predictive Value of Tests | Lung Neoplasms - mortality | Humans | Transcriptome | Tumor Microenvironment | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Biomarkers, Tumor - antagonists & inhibitors | Lung Neoplasms - genetics | Risk Assessment | Signal Transduction | Carcinoma, Non-Small-Cell Lung - genetics | Risk Factors | Treatment Outcome | B7-H1 Antigen - immunology | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Non-Small-Cell Lung - immunology | Antineoplastic Agents, Immunological - adverse effects | Lung Neoplasms - immunology | B7-H1 Antigen - antagonists & inhibitors | Antineoplastic Agents, Immunological - therapeutic use | Biomarkers, Tumor - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Programmed Cell Death 1 Receptor - immunology | Biomarkers, Tumor - immunology | Immune response | Lung cancer, Non-small cell | Biological markers | Tumors | Cell survival | Toxicity | Non-small cell lung carcinoma | Anticancer properties | Immune checkpoint | Peripheral blood | Biomarkers | Immune system | Apoptosis | Cancer | Index Medicus
Journal Article
The European respiratory journal, ISSN 0903-1936, 12/2015, Volume 46, Issue 6, pp. 1541 - 1543
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 11/2015, Volume 350, Issue 6264, pp. 1079 - 1084
REPORTS | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Germ-Free Life - immunology | Humans | Ipilimumab | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Intestines - immunology | Dysbiosis - immunology | Immunotherapy | Aged, 80 and over | Adult | Female | Skin Neoplasms - therapy | Bacteroides - immunology | Mice, Inbred C57BL | CTLA-4 Antigen - immunology | Fecal Microbiota Transplantation | Animals | Gastrointestinal Microbiome - drug effects | Intestines - microbiology | Immunologic Memory | T-Lymphocytes - immunology | Aged | Anti-Bacterial Agents - pharmacology | Mice | Gastrointestinal Microbiome - immunology | CTLA-4 Antigen - antagonists & inhibitors | Melanoma - therapy | Usage | Cell receptors | Care and treatment | Microbiota (Symbiotic organisms) | Health aspects | Methods | Cancer | Stomach | Microbiology | Cells | Index Medicus | Microorganisms | Effectiveness | Antibodies | Patients | Tumors | Anticancer properties | Life Sciences
Journal Article
Cancer treatment reviews, ISSN 0305-7372, 11/2017, Volume 60, pp. 60 - 68
Immunosenescence | Anti-PD1/PD-L1 mAb | Immune checkpoint inhibitors | Elderly | Age | Non-small cell lung cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Carcinoma, Non-Small-Cell Lung - immunology | Lung Neoplasms - drug therapy | Cell Cycle Checkpoints | Immunotherapy - methods | Lung Neoplasms - immunology | Humans | Antineoplastic Agents - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Immunity, Cellular | Molecular Targeted Therapy - methods | Lung cancer, Small cell | Care and treatment | T cells | Lung cancer, Non-small cell | Analysis | Immunotherapy | Index Medicus
Journal Article
Cell research, ISSN 1001-0602, 2015, Volume 25, Issue 2, pp. 208 - 224
免疫治疗 | 抗癌作用 | 可溶性 | 生物标志物 | CTLA-4 | IL-2 | 细胞毒性T淋巴细胞 | sCD25 | tumor immunotherapy | ipilimumab | cancer | CTLA-4 blockade | CD122 | Index Medicus | Life Sciences | Immunotherapy | Immunology
Journal Article